Delivery Order SPE2DB20D2104-SPE2DB21FR80R
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides a range of pharmaceutical products and medical supplies to support various government healthcare programs, particularly within the Department of Defense (DoD) and Department of Veterans Affairs (VA). The contract, valued at $3,755.67, is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, worth up to...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides a wide range of pharmaceutical products and medical supplies to support the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare programs. The award, valued at $81,182.18, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 and running through...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides a wide range of pharmaceutical products and medical supplies to the U.S. government, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The contract, valued at $1,387.26, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, worth up to $999,999,999.00 and...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of a wide range of pharmaceutical products and medical supplies to support the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The contract, valued at $1,473.47, is a delivery order issued under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, which has a ceiling value of...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides a wide range of pharmaceutical products and medical supplies to support the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The award, valued at $2,316.00, is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, worth up to $999,999,999.00 and running through November 2026. This...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of a wide range of pharmaceutical products and medical supplies to support the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The contract, valued at $1,123.53, is a delivery order issued under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, which has a ceiling value of $999,999,999...
- This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, provides a range of pharmaceutical products and medical supplies to support the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The $1,354.98 delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the Defense Logistics Agency (DLA) Troop Support Medical, running through November 2026. This IDC serves as the...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides a wide range of pharmaceutical products and medical supplies to support the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The contract, valued at $1,316.63, is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides a broad range of pharmaceutical products and medical supplies to support the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The $7,906.49 delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical. This IDC serves as the primary vehicle for...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide a wide range of pharmaceutical products and medical supplies to support the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is a delivery order valued at $7,595.57. It is part of a larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB21FR80RDelivery Order
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides a wide range of pharmaceutical products and medical supplies to support the U.S. Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The contract, valued at $9,908.56, is a delivery order issued under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, which has a ceiling value of $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and medical devices, to military treatment facilities and VA healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen's parent company, Cencora, Inc., also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 2/10/21 |